Ebalzotan (NAE-086) je selektivni agonist 5-HT1A receptor.[4][5] On je bio u razvoju kao antidepresiv i anksiolitik, ali je proizvodio nepoželjne nuspojave u fazi I kliničkih ispitivanja te je njegov razvoj prekinut.[4][5]

Ebalzotan
(IUPAC) ime
(3R)-N-(propan-2-il)-3-[propan-2-il(propil)amino]-3,4-dihidro-2H-hromen-5-karboksamid
Klinički podaci
Identifikatori
CAS broj 149494-37-1
ATC kod nije dodeljen
PubChem[1][2] 9797080
ChemSpider[3] 7972846
UNII WV4B56N49H DaY
Hemijski podaci
Formula C19H30N2O2 
Mol. masa 318,45 g/mol
SMILES eMolekuli & PubHem
Farmakoinformacioni podaci
Trudnoća ?
Pravni status Uncontrolled
Način primene Oralno

Vidi još uredi

Spoljašnje veze uredi

Reference uredi

  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. 4,0 4,1 Tamim Braish; Gadamasetti, Kumar G. (2008). Process chemistry in the pharmaceutical industry, volume 2 challenges in an ever changing climate. Boca Raton: CRC Press. ISBN 0-8493-9051-6. 
  5. 5,0 5,1 Weaver, Donald F.; Nogrady, Thomas; Nogrady, Th (2005). Medicinal chemistry a molecular and biochemical approach. Oxford [Oxfordshire]: Oxford University Press. ISBN 0-19-510455-2. 


Literatura uredi